Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Armata Pharmaceuticals, Inc. | v416704_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - Armata Pharmaceuticals, Inc. | v416704_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Armata Pharmaceuticals, Inc. | v416704_ex31-1.htm |
| EX-32.2 - EXHIBIT 32.2 - Armata Pharmaceuticals, Inc. | v416704_ex32-2.htm |
Exhibit 32.1
AMPLIPHI BIOSCIENCES CORPORATION
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of AmpliPhi Biosciences Corporation (the “Company”) on Form 10-Q for the period ended June 30, 2015 as filed with the Securities and Exchange Commission (the “Report”), I, Michael Scott Salka, Chief Executive Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.
Date: August 13, 2015
| /s/ Michael Scott Salka | |
| Michael Scott Salka | |
| Chief Executive Officer |